Health · 1 sources covering this

STAT+: Obesity drugmakers are testing in kids as young as 6

Vera seeks kidney drug approval, early data from Syntis Bio, and other biotech news from The Readout

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Obesity drugmakers are testing in kids as young as 6
Vera seeks kidney drug approval, early data from Syntis Bio, and other biotech news from The Readout
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/af4f7749c5c9b23be6c65f43d8c6dfe12c583d72"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Obesity drugmakers are testing in kids as young as 6"></iframe>

STAT+: Obesity drugmakers are testing in kids as young as 6

How 1 sources are covering this

STAT+: Obesity drugmakers are testing in kids as young as 6

More from Health

STAT+: RFK Jr. returns to his roots

STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases

STAT+: FDA takes applications for new program to shorten drug approval times

STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Obesity drugmakers are testing in kids as young as 6

More from Health

STAT+: RFK Jr. returns to his roots

STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases

STAT+: FDA takes applications for new program to shorten drug approval times

STAT+: Pharmalittle: We&#8217;re reading about a GSK deal for a drug from China, job losses in the U.S., and more

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more